Blog
 » 
Infection
 » 
Antibiotic Resistance in MRSP Infections

Antibiotic Resistance in MRSP Infections

Infection

X min read

Owners

Understand why MRSP infections are antibiotic resistant, how resistance develops, and what it means for treatment choices and long-term infection control in dogs.

By 

Sustainable Vet Group

Updated on

August 13, 2026

.

This article is for informational purposes only and is not a substitute for professional veterinary advice. Every case is unique, so always consult your veterinarian for guidance specific to your pet.

This content is intended for veterinary professionals for educational purposes. It does not replace clinical judgment or tailored advice. Always rely on your training, expertise, and the specific context of your patients.

Antibiotic Resistance in MRSP Infections

Antibiotic resistance in MRSP is not just one drug not working. It is often multiple drug classes failing simultaneously, and understanding why helps you see why treatment decisions require laboratory guidance rather than educated guessing.

MRSP's resistance profile is driven by genetics, not chance. And those genetics can be tested, mapped, and used to find what still works.

 

Quick answer: MRSP acquires antibiotic resistance primarily through the mecA gene, which encodes a modified penicillin-binding protein that renders all beta-lactam antibiotics ineffective. Most MRSP isolates also carry resistance to 2 or more additional antibiotic classes, making them multidrug-resistant (MDR). A Belgian study found 99% of canine MRSP isolates were MDR. Treatment requires culture and sensitivity testing to identify which specific antibiotics retain activity against the individual isolate.

 

Key takeaways

  • The mecA gene is the core resistance mechanism: it disables the target site for all beta-lactam antibiotics.
  • 99% of MRSP isolates in dogs are multidrug-resistant, per a 2025 Belgian study.
  • Resistance extends beyond beta-lactams to clindamycin, fluoroquinolones, tetracyclines, and gentamicin.
  • Two geographic clones exist: North American and European, with different resistance profiles.
  • Culture and sensitivity testing is the only reliable guide to effective antibiotic selection.
  • Topical antiseptics work regardless of resistance: chlorhexidine remains active against MRSP.

How MRSP acquires antibiotic resistance

The mecA gene: the foundation of MRSP resistance

MRSP becomes methicillin-resistant when it acquires the mecA gene. This gene encodes a modified penicillin-binding protein (PBP2a) that no longer binds to beta-lactam antibiotics.

Normal bacteria: beta-lactam antibiotics (penicillins, cephalosporins) bind to penicillin-binding proteins on the bacterial cell wall, preventing cell wall synthesis, and killing the bacterium.

MRSP with mecA: PBP2a replaces normal PBPs. Beta-lactam antibiotics cannot bind to PBP2a. The bacteria continue building cell walls and survive.

The result: all beta-lactam antibiotics fail simultaneously in mecA-positive MRSP: not just methicillin, but every drug in the beta-lactam class.

This includes:

  • Amoxicillin and amoxicillin-clavulanate (Clavamox)
  • Cephalexin (Keflex)
  • Cefpodoxime (Simplicef)
  • Cefovecin (Convenia)
  • All other cephalosporins and penicillins used in veterinary practice

Co-resistance: why MRSP is multidrug-resistant

The mecA gene doesn't travel alone. It's carried on mobile genetic elements (SCCmec cassettes) that often bring additional resistance genes along.

A 2024 published study (PMC11394641) found that all oxacillin-resistant MRSP isolates exhibited multidrug resistance. Even among isolates that carried mecA but were phenotypically oxacillin-susceptible, 44.4% showed multidrug resistance.

Royal Canin Academy confirms: "The problem with MRSP is not only beta-lactam resistance but also resistance to other antibiotics such as clindamycin, erythromycin, fluoroquinolones, gentamicin, and tetracycline."

What MRSP is typically resistant to

The resistance profile varies by isolate, which is why culture testing matters. However, common resistance patterns include:

Antibiotic ClassExamplesMRSP Resistance Status
Beta-lactams (all)Amoxicillin, cephalexin, Clavamox, ConveniaResistant (all MRSP by definition)
LincosamidesClindamycinOften resistant
MacrolidesErythromycinOften resistant
FluoroquinolonesEnrofloxacin, marbofloxacinFrequently resistant
AminoglycosidesGentamicinVariable; frequently resistant
TetracyclinesDoxycycline, tetracyclineVariable; frequently resistant
SulfonamidesTrimethoprim-sulfaVariable
ChloramphenicolChloramphenicolSometimes active (especially North American clone)
RifampicinRifampinSometimes active; must be used in combination
Fusidic acidFusidic acidSometimes active (especially European clone)

 

 

Critical fact: A Belgian study published in 2025 found that 99% of canine MRSP isolates were multidrug-resistant organisms (MDROs), compared to 83.3% of MRSA isolates from dogs. MRSP shows broader multidrug resistance than MRSA in companion animals.

 

Geographic variation: North American vs. European clones

Two major MRSP lineages have spread globally, and they have different resistance profiles.

North American clone (ST68):

  • Resistant to most beta-lactams, fluoroquinolones, and aminoglycosides
  • Often susceptible to chloramphenicol, rifampicin, and amikacin

European clone (ST71):

  • Broad multidrug resistance pattern
  • Often susceptible to fusidic acid and doxycycline/minocycline
  • Resistant to chloramphenicol in many isolates

Royal Canin Academy notes: "Two clonal MRSP lineages developed simultaneously in Europe and the US with different resistant patterns."

Practical implication for US owners: If your dog has MRSP, the North American clone may retain susceptibility to chloramphenicol, amikacin, or rifampicin. Culture and sensitivity results will confirm this for your dog's specific isolate.

How antibiotic misuse drives resistance

MRSP doesn't develop its resistance profile in a vacuum. Antibiotic use history is a primary driver.

What creates resistance in S. pseudintermedius populations:

  • Short antibiotic courses: bacteria that survive incomplete courses adapt to resist future exposure
  • Wrong antibiotic choice: using a drug to which MRSP is already resistant exerts selective pressure without treating the infection
  • Beta-lactam use in MRSP cases: beta-lactam antibiotics are specifically known to select for MRSP colonization, per Today's Veterinary Practice
  • Empiric switching: switching from one antibiotic class to another without culture guidance is explicitly warned against for MRSP. Royal Canin Academy states it is "not advisable to empirically switch from one antibiotic class to another if treatment fails with the first-line antimicrobial"

A published case study (PMC10223261) demonstrated direct antibiotic selective pressure: treatment with amikacin for one pathogen caused emergence of MRSP from the nasal cavity of the same dog during the treatment course.

What still works against MRSP

Despite broad resistance, several treatment options remain depending on the individual isolate's sensitivity results:

Topical treatments (active regardless of antibiotic resistance):

  • Chlorhexidine 2 to 4% shampoos, sprays, and mousses
  • PHMB (polyhexamethylene biguanide)-based solutions
  • Mupirocin ointment (for localized lesions)
  • Fusidic acid gel (for localized lesions, if susceptible)

Systemic options (always guided by culture and sensitivity):

  • Chloramphenicol (oral; US clone often susceptible)
  • Rifampicin (must be used in combination; resistance develops quickly if used alone)
  • Amikacin (injectable; reserved for severe infections)
  • Doxycycline/minocycline (European clone; variable US susceptibility)

 

The topical-first principle: For surface and superficial infections, topical antiseptic therapy alone is often effective against MRSP, regardless of resistance profile. This avoids systemic antibiotic exposure entirely.

 

For practical treatment approaches guided by these resistance considerations, see practical treatment despite resistance. For treatment guidelines that account for resistance, see treatment guidelines that account for resistance. For the full overview of MRSP causes and symptoms, see MRSP overview. For all treatment options available for MRSP, see treatment options given resistance challenges.

Why empiric antibiotic switching fails

When an antibiotic course fails, the instinct is to try a different antibiotic. For MRSP, this approach often makes things worse.

Because MRSP typically carries resistance to multiple drug classes simultaneously, switching from cephalexin to clindamycin, then to enrofloxacin, exposes the bacteria to three antibiotics while potentially only adding resistance pressure, not effective treatment.

Royal Canin Academy is explicit: "S. pseudintermedius with resistance to three or more classes of antibiotic is classified as multidrug resistant, and it is therefore not advisable to empirically switch from one antibiotic class to another if treatment fails with the first-line antimicrobial."

The correct path: Culture and sensitivity testing before any antibiotic change. Use only the antibiotics the result identifies as susceptible.

For how resistance affects management of recurrent cases, see managing resistance in recurrent cases. For resistance in the broader context of MRSA and MRSP, see resistance in the broader context of MRSA and MRSP.

Frequently asked questions

If MRSP is resistant to so many antibiotics, how does it ever get cured?

Two reasons. First, "resistant to many antibiotics" is not the same as "resistant to all antibiotics." Culture and sensitivity testing identifies the specific drugs that retain activity against the individual isolate. Second, topical antiseptics (chlorhexidine, PHMB) work through physical disruption of bacterial membranes, not antibiotic mechanisms: MRSP cannot become resistant to them the same way it can to antibiotics.

Is MRSP getting more resistant over time?

Yes, in the general sense. Published literature consistently shows increasing multidrug resistance in S. pseudintermedius isolates over time, driven by antibiotic use in veterinary and human medicine. The North American and European clonal lineages continue to acquire additional resistance genes. This is the global concern driving antimicrobial stewardship efforts in veterinary practice.

Should my dog's MRSP be reported anywhere?

In the US, there is no mandatory reporting requirement for MRSP in dogs at the national level. However, if your dog was hospitalized and is diagnosed with MRSP, the veterinary hospital may implement infection control measures and flag the case internally. Specialist veterinary dermatologists and diagnostic laboratories track resistance patterns through surveillance programs.

MRSP's antibiotic resistance is not a mystery: it's genetics. The mecA gene, the mobile resistance elements, and the multidrug-resistant profile it creates are known and documentable. That's why culture and sensitivity testing resolves the treatment question: it maps exactly which drugs the individual isolate is susceptible to, in a way that no clinical assessment alone can.

Resources

  • Royal Canin Academy. Canine pyoderma: the problem of methicillin resistance. academy.royalcanin.com
  • Depoorter et al. Antimicrobial Resistance of MRSA and MRSP Isolates from Clinical Cases in Dogs and Cats in Belgium. MDPI, 2025. mdpi.com
  • Grönlund Andersson et al. Characterization of Oxacillin-Resistant mecA-Positive S. pseudintermedius from Skin Lesions of Dogs. PMC, 2024. pmc.ncbi.nlm.nih.gov
  • Today's Veterinary Practice. Methicillin-Resistant Staphylococcal Infections: Recent Developments. todaysveterinarypractice.com

Get a Free Poster

Enhance your workspace with a high-quality radiographs reference poster, designed for veterinary professionals. This free physical poster will be shipped directly to you—just fill out the form to request your copy.

Things to know

Get a Free Poster for Your Clinic

Enhance your workspace with a high-quality radiographs reference poster, designed for veterinary professionals. This free physical poster will be shipped directly to you—just fill out the form to request your copy.

We'd love you to
Join Us!

Enter Your Details Below to Receive Your Information Pack

100% safe & secure. Your details are never shared or sold.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Taking Great TPLO Radiographs

Click Below to Watch Live Video Demos

We'll send you a Free Wall Poster with all the steps

Now that you are a pro at TPLO rads

Let's take your infection control to the next level

Watch these videos!

Step #1

Getting Ready

Ensuring a clean surgical field starts with proper skin preparation. This video demonstrates the best practices for:

  • Shaving the patient – Achieving a close, even shave while minimizing skin irritation
  • The Dirty Scrub – The initial skin prep step to remove surface debris and reduce bacterial load before the sterile scrub.

Following these techniques helps reduce infection risk and improve surgical outcomes. Watch the video to see how it’s done effectively!

Step #2

Reduce Your Risks

Many surgeons are shocked to find out that their patients are not protected from biofilms and resistant bacteria when they use saline and post-op antibiotics.

That’s Where Simini Comes In.

Why leave these risks and unmanaged?  Just apply Simini Protect Lavage for one minute. Biofilms and resistant bacteria can be removed, and you can reduce two significant sources of infection.

Step #3

Take the Course

Preventing surgical infections is critical for patient safety and successful outcomes. This course covers:

  • Aseptic techniques – Best practices to maintain a sterile field.
  • ​Skin prep & draping – Proper methods to minimize contamination.
  • ​Antibiotic stewardship – When and how to use perioperative antibiotics effectively.

Stay up to date with the latest evidence-based protocols. Click the link to start learning and earn CE credits!

Get Your
Free Poster!

Enter your information below, and we’ll ship it to you at no cost.

Do you want to customize it?

How many would you like?

About you

Shipping information

100% safe & secure. Your details are never shared or sold.

We will work on your request shortly.
Oops! Something went wrong while submitting the form.
What’s your role in animal care?

Tell us who you are so we can guide you to the most relevant information.